Class action lawsuit opened for victims of deadly Spanish painkiller

Published:  15 Nov at 6 PM
Want to get involved? Become a Featured Expat and take our interview.
Become a Local Expert and contribute articles.
Get in touch today!
Tagged: Spain
The manufacturers and distributors of Nolitil, the deadly painkiller which killed expats in Spain, are now facing a class action lawsuit.

The deadly drug was first exposed as a killer in Spain’s expat newspaper The Olive Press after medical translator Cristina del Campo alerted a journalist at the publication. After an almost two year battle to have the drug regulated and its deadly effects publicised, the paper’s campaign resulted in getting it banned for tourists and expats can only be prescribed it short term after a thorough analysis of the patient’s heritage and medical history.

Finally convinced by del Campo’s continuing research and the paper’s involvement, the Spanish Medical Agency has issued a directive to the country’s healthcare providers to refuse the drug to Irish and British tourists, and closer monitoring of its effects is now mandatory. As a result, over 200 individual expat victims of the drug’s side effects have now launched a class action against its manufacturer and distributors. The case will be presented by Palma de Mallorca-based international legal firm De Micco and Friends, collectively representing all the sufferers and claiming damages.

Victims of Novotil who wish to be included should register for free on De Micco’s website, giving just a few brief details and a description of how the drug has harmed them. Other details on the website state the firm will represent class action claimants and individuals alike, and it’s believed the families of the dozens who died as a result of taking the drug will also be involved. Both the Olive Press and del Campo are relieved their campaign has been successful and are urging everyone affected to sign up for the class action suit.
Like this news?

Comments » No published comments just yet for this article...

Feel free to have your say on this item. Go on... be the first!

Tell us Your Thoughts On This Piece:

Your Name *
Email * (not published, needs verification one time only)
  • Facebook
  • Follow us on Twitter
  • RSS feed
  • Facebook

Latest Headlines

News Links

News Archive